0000000000426608

AUTHOR

Pierre Emmanuel Charles

showing 14 related works from this author

Mechanical ventilation alters the development of staphylococcus aureus pneumonia in rabbit

2016

Ventilator-associated pneumonia (VAP) is common during mechanical ventilation (MV). Beside obvious deleterious effects on muco-ciliary clearance, MV could adversely shift the host immune response towards a pro-inflammatory pattern through toll-like receptor (TLRs) up-regulation. We tested this hypothesis in a rabbit model of Staphylococcus aureus VAP. Pneumonia was caused by airway challenge with S. aureus, in either spontaneously breathing (SB) or MV rabbits (n = 13 and 17, respectively). Pneumonia assessment regarding pulmonary and systemic bacterial burden, as well as inflammatory response was done 8 and 24 hours after S. aureus challenge. In addition, ex vivo stimulations of whole blood…

0301 basic medicinePulmonologyPhysiologyStaphylococcusmedicine.medical_treatment[SDV]Life Sciences [q-bio]lcsh:MedicinePharmacologyPathology and Laboratory Medicinemedicine.disease_causeStaphylococcal/immunology/pathologyImmune ReceptorsBiochemistry0302 clinical medicineImmune PhysiologyPneumonia StaphylococcalMedicine and Health SciencesMedicineStaphylococcus Aureuslcsh:ScienceImmune ResponseToll-like ReceptorsMammalsddc:616Innate Immune SystemImmune System ProteinsMultidisciplinaryddc:617RespirationPneumonia Ventilator-AssociatedInterleukinAnimal ModelsHematologyBacterial PathogensBody Fluids3. Good healthBloodmedicine.anatomical_structureMedical MicrobiologyStaphylococcus aureusVertebratesArtificialCytokinesRabbitsPathogensAnatomymedicine.symptomStaphylococcus aureus/immunologyResearch ArticleSignal TransductionToll-Like Receptor 2/immunologyImmunologyInflammationLung injuryResearch and Analysis MethodsMicrobiology03 medical and health sciencesModel OrganismsSigns and SymptomsDiagnostic MedicineAnimalsMicrobial PathogensInflammationMechanical ventilationInterleukin-8/immunologyLung[ SDV ] Life Sciences [q-bio]BacteriaTumor Necrosis Factor-alphabusiness.industrylcsh:RInterleukin-8OrganismsBiology and Life SciencesProteins030208 emergency & critical care medicineCell BiologyPneumoniaMolecular Developmentmedicine.diseaseTumor Necrosis Factor-alpha/immunologyRespiration ArtificialToll-Like Receptor 2Pneumonia030104 developmental biologyVentilator-Associated/immunology/microbiology/pathologyImmune SystemAmniotesImmunologylcsh:QbusinessSpleenEx vivoDevelopmental Biology
researchProduct

Role of biomarkers in the management of antibiotic therapy : an expert panel review : I - currently available biomarkers for clinical use in acute in…

2013

Abstract In the context of worldwide increasing antimicrobial resistance, good antimicrobial prescribing in more needed than ever; unfortunately, information available to clinicians often are insufficient to rely on. Biomarkers might provide help for decision-making and improve antibiotic management. The purpose of this expert panel review was to examine currently available literature on the potential role of biomarkers to improve antimicrobial prescribing, by answering three questions: 1) Which are the biomarkers available for this purpose?; 2) What is their potential role in the initiation of antibiotic therapy?; and 3) What is their role in the decision to stop antibiotic therapy? To ans…

medicine.medical_specialtymedicine.drug_class[SDV.MHEP.PHY] Life Sciences [q-bio]/Human health and pathology/Tissues and Organs [q-bio.TO]AntibioticsMEDLINEContext (language use)ReviewCritical Care and Intensive Care MedicineProcalcitoninC-reactive proteinsuPARsepsis03 medical and health sciences0302 clinical medicineAntibiotic resistanceemergency medicineAntibiotic therapy[SDV.MHEP.PHY]Life Sciences [q-bio]/Human health and pathology/Tissues and Organs [q-bio.TO]Medicine030212 general & internal medicineIntensive care medicine030304 developmental biologyddc:6160303 health sciencessepticemie[ SDV.MHEP.PHY ] Life Sciences [q-bio]/Human health and pathology/Tissues and Organs [q-bio.TO]business.industryPresepsin[ SDV.SPEE ] Life Sciences [q-bio]/Santé publique et épidémiologieproADMsTREM-1infection3. Good healthSanté publique et épidémiologie[SDV.SPEE] Life Sciences [q-bio]/Santé publique et épidémiologieBiomarker (medicine)infection;sepsis;emergency medicine;biomarker;procalcitonin;C-reactive protein;sTREM-1;suPAR;proADM;resepsinbiomarker[SDV.SPEE]Life Sciences [q-bio]/Santé publique et épidémiologieresepsinbusinessbiomarqueurBiomarkersprocalcitonin
researchProduct

A New Prognosis Score to Predict Mortality After Acute Pneumonia in Very Elderly Patients

2016

International audience; Objectives: Acute pneumonia (AP) induces an excess of mortality among the elderly. We evaluated the value of a new predictive biomarker index compared to usual prognosis scores for predicting in-hospital and 1-year mortalities in elderly inpatients with AP.Design: Retrospective study in 6 clinical departments of a university hospital.Setting: Burgundy university hospital (France).Participants: All patients aged 75 and over with AP and hospitalized between January 1 and June 30, 2013, in the departments of medicine (5) and intensive care (1) of our university hospital.Measurements: A new index, which we named UBMo, was created by multiplying the uremia (U in the formu…

Malecommunity-acquired pneumoniaPneumonia severity indexseveritysepsis0302 clinical medicineElderlyadultsscoreHospital Mortality030212 general & internal medicineProspective cohort studyGeneral NursingAged 80 and overvalidation[SDV.MHEP.GEG]Life Sciences [q-bio]/Human health and pathology/Geriatry and gerontologyHealth PolicyMortality rateGeneral Medicinecohort3. Good healthAcute DiseaseFemaleFranceterm survivalmanagementmedicine.medical_specialtyhospitalized-patients[ SDV.MHEP.GEG ] Life Sciences [q-bio]/Human health and pathology/Geriatry and gerontology03 medical and health sciencesPredictive Value of TestsIntensive careInternal medicinemedicineHumanspneumoniaIntensive care medicineAgedRetrospective Studiesbusiness.industrybiomarkersRetrospective cohort studymedicine.diseasemortalityUremiaPneumoniaBlood pressure030228 respiratory systemprognosisGeriatrics and Gerontologybusiness
researchProduct

Mild-stretch mechanical ventilation upregulates toll-like receptor 2 and sensitizes the lung to bacterial lipopeptide.

2011

Introduction Mechanical ventilation (MV) could prime the lung toward an inflammatory response if exposed to another insult such as bacterial invasion. The underlying mechanisms are not so far clear. Toll-like receptors (TLRs) allow the host to recognize selectively bacterial pathogens and in turn to trigger an immune response. We therefore hypothesized that MV modulates TLR2 expression and in turn modifies responsiveness to agonists such as bacterial lipopeptide (BLP). Method Both in vitro and in vivo experiments were conducted. First, TLR2 expression and protein were measured in the A549 pulmonary epithelial cell line submitted to 8-hour cyclic stretch (20% elongation; 20/minute rate). Aft…

MaleInterleukin-6/metabolismCell Culture TechniquesRespiration Artificial/methodsBiologyLung injuryCritical Care and Intensive Care MedicineReal-Time Polymerase Chain Reaction03 medical and health scienceschemistry.chemical_compoundLipopeptidesToll-Like Receptor 2/analysis/genetics/metabolism0302 clinical medicineImmune systemLipopeptides/metabolismDownregulation and upregulationAnimalsReceptorLung030304 developmental biologyddc:616A549 cell0303 health sciencesToll-like receptorEpithelial Cells/metabolism/microbiologyddc:617BacteriaInterleukin-6ResearchInterleukin-8Lipopeptide030208 emergency & critical care medicineEpithelial CellsSequence Analysis DNArespiratory systemFlow CytometryRespiration ArtificialLung/immunology/metabolismToll-Like Receptor 23. Good healthCell biologyUp-RegulationTLR2chemistryInterleukin-8/metabolismBacteria/metabolismImmunologyRabbitsCritical care (London, England)
researchProduct

Fungal sepsis in the ICU: are we doing better? Trends in incidence, diagnosis, and outcome

2013

équipe EA pôle MERS Hors CT hors EJ

[SDV] Life Sciences [q-bio][SDE] Environmental Sciences[SDV]Life Sciences [q-bio][SDE]Environmental Sciences[SDV.BV]Life Sciences [q-bio]/Vegetal Biology[SDV.BV] Life Sciences [q-bio]/Vegetal Biologycandidiasis
researchProduct

Linezolid and atorvastatin impact on pneumonia caused by Staphyloccocus aureus in rabbits with or without mechanical ventilation

2017

International audience; Pneumonia may involve methicillin-resistant Staphylococcus aureus (MRSA), with elevated rates of antibiotics failure. The present study aimed to assess the effect of statins given prior to pneumonia development. Spontaneously breathing (SB) or mechanically ventilated (MV) rabbits with pneumonia received atorvastatin alone, linezolid (LNZ) alone, or a combination of both (n = 5 in each group). Spontaneously breathing and MV untreated infected animals (n = 11 in each group), as well as uninfected animals (n = 5 in each group) were used as controls. Microbiological features and inflammation were evaluated. Data are presented as medians (interquartile range). Linezolid a…

0301 basic medicinePulmonologyPhysiologymedicine.medical_treatmentAtorvastatinStaphylococcuslcsh:MedicineInduced Lung Injurychemistry.chemical_compound0302 clinical medicineImmune PhysiologyMedicine and Health SciencesAtorvastatinlcsh:ScienceImmune ResponseLungPathology and laboratory medicineMammalsInnate Immune SystemMultidisciplinaryRespirationDrugsEukaryotaAnimal ModelsMedical microbiology3. Good healthBody FluidsUp-Regulationmedicine.anatomical_structureBloodExperimental Organism SystemsBreathingAnesthesiaVertebratesLeporidsCytokinesMethicillin-resistant Staphylococcus aureusRabbitsPathogensAnatomyIn-Vivomedicine.drugResearch Article[SDV.OT]Life Sciences [q-bio]/Other [q-bio.OT]Staphylococcus aureusStatinmedicine.drug_class030106 microbiologyImmunologyOutcomesResearch and Analysis MethodsMicrobiologySepsis03 medical and health sciencesSigns and SymptomsDiagnostic MedicineSepsismedicinePneumonia BacterialAnimalsTidal-VolumeMortality[ SDV.OT ] Life Sciences [q-bio]/Other [q-bio.OT]Mechanical ventilationPharmacologyInflammationLungBacteriabusiness.industrylcsh:ROrganismsLinezolidStatinsBiology and Life Sciences030208 emergency & critical care medicinePneumoniaMolecular Developmentmedicine.diseaseRespiration ArtificialToll-Like Receptor 2Microbial pathogensPneumoniachemistryBacteremiaImmune SystemLinezolidAmnioteslcsh:QBacterial pathogensbusinessPhysiological ProcessesDevelopmental BiologyModel
researchProduct

Mr-Proadm Elevation Upon Icu Admission Predicts the Outcome of Septic Patients and is Correlated with Upcoming Fluid Overload.

2017

IF 3.113; International audience; Background: Among septic patients admitted to the intensive care unit (ICU), early recognition of those with the highest risk of death is of paramount importance. We evaluated the prognostic value of Procalcitonin (PCT), mid regional-proadrenomedullin (MR-proADM), copeptine and CT-proendothelin 1 (CT-ProET 1) concentrations. Methods: This was a prospective cohort study, which included 173 septic patient admitted to one ICU. Blood samples for biomarker measure-ments were obtained upon admission and on day 5. The predictive value of each biomarker regarding the risk of death at day 28 was assessed. The fluid balance was evaluated from admission to day 5. Resu…

CalcitoninMalemedicine.medical_specialtyTime FactorsArbitrary unit030204 cardiovascular system & hematologyCritical Care and Intensive Care MedicineProcalcitoninDisease-Free Survivallaw.inventionSepsis03 medical and health sciencesAdrenomedullin0302 clinical medicine[SDV.MHEP.CSC]Life Sciences [q-bio]/Human health and pathology/Cardiology and cardiovascular systemlawInternal medicineSepsismedicine[ SDV.MHEP.HEM ] Life Sciences [q-bio]/Human health and pathology/HematologyHumansHospital MortalityProtein PrecursorsProspective cohort studyAgedAged 80 and overEndothelin-1business.industryGlycopeptides[SDV.MHEP.HEM]Life Sciences [q-bio]/Human health and pathology/Hematology030208 emergency & critical care medicine[ SDV.MHEP.CSC ] Life Sciences [q-bio]/Human health and pathology/Cardiology and cardiovascular systemMiddle Agedmedicine.diseaseIntensive care unit3. Good healthSurgeryIcu admissionFluid balanceClinical trialHospitalizationIntensive Care UnitsEmergency MedicineproadrenomedullinBiomarker (medicine)FemalebusinessprocalcitoninBiomarkersShock (Augusta, Ga.)
researchProduct

Impact of the Prone Position in an Animal Model of Unilateral Bacterial Pneumonia Undergoing Mechanical Ventilation

2013

Abstract Background: The prone position (PP) has proven beneficial in patients with severe lung injury subjected to mechanical ventilation (MV), especially in those with lobar involvement. We assessed the impact of PP on unilateral pneumonia in rabbits subjected to MV. Methods: After endobronchial challenge with Enterobacter aerogenes, adult rabbits were subjected to either “adverse” (peak inspiratory pressure = 30 cm H2O, zero end-expiratory pressure; n = 10) or “protective” (tidal volume = 8 ml/kg, 5 cm H2O positive end-expiratory pressure; n = 10) MV and then randomly kept supine or turned to the PP. Pneumonia was assessed 8 h later. Data are presented as median (interquartile range). Re…

Maleend-expiratory pressureSupine positionEndpoint Determinationmedicine.medical_treatmentrecruitment maneuverPeak inspiratory pressureLung injuryPulmonary compliancerabbit modelPositive-Pressure RespirationPneumonia BacterialProne PositionSupine PositionmedicineAnimalsratLungLung ComplianceTidal volumeInflammationMechanical ventilationrespiratory-distress-syndromecyclic stretchPulmonary Gas ExchangeTumor Necrosis Factor-alphabusiness.industryInterleukin-8Enterobacteriaceae InfectionsHemodynamicsEnterobacter aerogenesmedicine.diseaseRespiration ArtificialPneumoniaProne positiongas-exchangeAnesthesiology and Pain Medicineacute lung injuryAnesthesia[SDV.SPEE]Life Sciences [q-bio]/Santé publique et épidémiologieRabbitstidal volume ventilationbusinessair-space enlargementAnesthesiology
researchProduct

Specific Features of the Coagulopathy Signature in Severe COVID-19 Pneumonia

2021

Rationale: COVID-19 displays distinct characteristics that suggest a unique pathogenesis. The objective of this study was to compare biomarkers of coagulopathy and outcomes in COVID-19 and non-COVID-19 patients with severe pneumonia.Methods: Thirty-six non-COVID-19 and 27 COVID-19 non-immunocompromised patients with severe pneumonia were prospectively enrolled, most requiring intensive care. Clinical and biological characteristics (including plasma biomarkers of coagulopathy) were compared.Results: At similar baseline severity, COVID-19 patients required mechanical ventilation (MV) for significantly longer than non-COVID-19 patients (p = 0.0049) and more frequently developed venous thrombot…

Medicine (General)medicine.medical_specialtymedicine.medical_treatmentVCAM1030204 cardiovascular system & hematologymedicine.disease_causeGastroenterologycoagulopathyPathogenesis03 medical and health sciencesR5-9200302 clinical medicineIntensive careInternal medicinemedicineCoagulopathypneumonia030212 general & internal medicinethrombosisMechanical ventilationbusiness.industryCOVID-19General MedicineImmune dysregulationBrief Research Reportacute respiratory distress syndromemedicine.diseaseThrombosisClinical trialPneumoniaMedicinebusinessFrontiers in Medicine
researchProduct

Impact of a stay in the intensive care unit on the preparation of Advance Directives: Descriptive, exploratory, qualitative study.

2017

Abstract Background Our objective was to assess, through a qualitative, exploratory study, the thought processes of patients regarding the formulation of advance directives (AD) after a stay in the ICU. Methods The study was conducted from May to July 2016 using telephone interviews performed by four senior ICU physicians. Inclusion criteria were: patients discharged from ICU to home > 3 months earlier. Semi-directive interviews with patients focused on 5 main points surrounding AD. Results In total, among 159 eligible patients, data from 94 (59%) were available for analysis. Among all those interviewed, 83.5% had never heard of “advance directives”. Only 2% had executed AD before ICU admis…

CounselingMalemedicine.medical_specialtyCritical Caremedicine.medical_treatmentIntensive Care UnitExploratory researchCritical Care and Intensive Care MedicineAdvanced Cardiac Life SupportAdvance directiveslaw.invention03 medical and health sciences0302 clinical medicinelawSurveys and QuestionnairesmedicineHumans030212 general & internal medicineAgedMechanical ventilationAged 80 and overbusiness.industryPersistent Vegetative StateAdvanced cardiac life supportMinimally conscious state030208 emergency & critical care medicine[ SDV.SPEE ] Life Sciences [q-bio]/Santé publique et épidémiologieGeneral MedicineMiddle Agedmedicine.diseaseIntensive care unit3. Good healthIcu admissionPain IntractableTelephoneIntensive Care UnitsAnesthesiology and Pain MedicineEmergency medicineFemale[SDV.SPEE]Life Sciences [q-bio]/Santé publique et épidémiologieQualitative studybusinessInclusion (education)Medical FutilityVentilator WeaningQualitative research
researchProduct

Vasopressor Cumulative Dose Requirement and Risk of Early Death During Septic Shock: An Analysis From The EPISS Cohort

2018

Septic shock is the primary cause of death in intensive care units, with about 20% of patients dying in the first 3 days. To design future trials focused on early mortality, we require knowledge of early indicators that can detect patients at high risk of early death from refractory septic shock.The aim of this study was to assess whether the cumulative dose of vasopressors (CDV), calculated as the cumulative dose of epinephrine + norepinephrine, is a predictor of early death (within 72 hours) attributable to refractory septic shock (EDASS). This substudy of the EPISS trial was based on 370 patients admitted to a French ICU for septic shock between 2009 and 2011. The area under the receivin…

Malemedicine.medical_specialty030204 cardiovascular system & hematologyCritical Care and Intensive Care MedicineDisease-Free Survival03 medical and health sciences0302 clinical medicineRisk FactorsInternal medicineIntensive caremedicineHumansVasoconstrictor AgentsProspective StudiesIntensive care medicineProspective cohort studySurvival rateAgedCause of deathAged 80 and overCumulative doseSeptic shockbusiness.industry030208 emergency & critical care medicineMiddle Agedmedicine.diseaseShock SepticSurvival RateIntensive Care UnitsROC CurveShock (circulatory)CohortEmergency MedicineFemalemedicine.symptombusinessShock
researchProduct

Role of biomarkers in the management of antibiotic therapy: an expert panel review II: clinical use of biomarkers for initiation or discontinuation o…

2013

Abstract Biomarker-guided initiation of antibiotic therapy has been studied in four conditions: acute pancreatitis, lower respiratory tract infection (LRTI), meningitis, and sepsis in the ICU. In pancreatitis with suspected infected necrosis, initiating antibiotics best relies on fine-needle aspiration and demonstration of infected material. We suggest that PCT be measured to help predict infection; however, available data are insufficient to decide on initiating antibiotics based on PCT levels. In adult patients suspected of community-acquired LRTI, we suggest withholding antibiotic therapy when the serum PCT level is low (<0.25 ng/mL); in patients having nosocomial LRTI, data are insuf…

medicine.medical_specialty[SDV.MHEP.PHY] Life Sciences [q-bio]/Human health and pathology/Tissues and Organs [q-bio.TO]medicine.drug_class[SHS.INFO]Humanities and Social Sciences/Library and information sciencesAntibioticsReviewpneumonia;meningitis;pancreatitis;infection;sepsis;emergency medicine;biomarkers;procalcitonin;C-reactive proteinCritical Care and Intensive Care Medicine[SHS.INFO] Humanities and Social Sciences/Library and information sciencesProcalcitoninC-reactive proteinSepsis03 medical and health sciences0302 clinical medicineLower respiratory tract infectionSepsismedicine[SDV.MHEP.PHY]Life Sciences [q-bio]/Human health and pathology/Tissues and Organs [q-bio.TO][ SHS.INFO ] Humanities and Social Sciences/Library and information sciencesMeningitis030212 general & internal medicineIntensive care medicine: Infectionddc:6160303 health sciences030306 microbiologybusiness.industry[ SDV.MHEP.PHY ] Life Sciences [q-bio]/Human health and pathology/Tissues and Organs [q-bio.TO]Pneumoniamedicine.disease3. Good healthDiscontinuationPneumoniaPancreatitisPancreatitisEmergency medicineInfectionbusinessMeningitisProcalcitoninBiomarkersAnnals of Intensive Care
researchProduct

Impact de la modulation de la réponse inflammatoire pulmonaire et systémique de l'hôte mediée par Toll-Like Receptor 2 dans un modèle animal de pneum…

2012

[SDV] Life Sciences [q-bio][SDE] Environmental Sciences[SDV]Life Sciences [q-bio][SDE]Environmental Sciences[SDV.BV]Life Sciences [q-bio]/Vegetal Biology[SDV.BV] Life Sciences [q-bio]/Vegetal Biology
researchProduct

Adaptation de Candida albicans dans les tissus humains: du commensalisme à la pathogénicité

2012

National audience; Candida albicans (C. albicans) est un micro-organisme eucaryote appartenant à la flore commensale des muqueuses de l’homme sain. Ce commensalisme résulte d’un équilibre entre la levure et les systèmes de défense de l’hôte. La rupture de cet équilibre chez un patient fragilisé (sujet infecté par le VIH, neutropénique, cancéreux, transplanté ou séjournant en service de réanimation) favorisera une colonisation intense des muqueuses, un envahissement de la barrière digestive et enfin la possibilité de dissémination hématogène. Les candidémies restent des infections graves puisque la mortalité directement attribuable à l’infection est estimée à 38%. Nos travaux ont d’abord por…

[SDV] Life Sciences [q-bio][SDE] Environmental Sciences[SDV]Life Sciences [q-bio][SDE]Environmental SciencesCandida albicans[SDV.BV]Life Sciences [q-bio]/Vegetal Biology[SDV.BV] Life Sciences [q-bio]/Vegetal Biology
researchProduct